Home LiteratureArticle Details
PMID: 12373602 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The association of breast mitogens with mammographic densities.

British journal of cancer ·Vol. 87 ·No. 8 ·2002-10-07 ·Pages 876-82

Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S

Abstract

Radiologically dense breast tissue (mammographic density) is strongly associated with risk of breast cancer, but the biological basis for this association is unknown. In this study we have examined the association of circulating levels of hormones and growth factors with mammographic density. A total of 382 subjects, 193 premenopausal and 189 postmenopausal, without previous breast cancer or current hormone use, were selected in each of five categories of breast density from mammography units. Risk factor information, anthropometric measures, and blood samples were obtained, and oestradiol, progesterone, sex hormone binding globulin, growth hormone, insulin-like growth factor-I and its principal binding protein, and prolactin measured. Mammograms were digitised and measured using a computer-assisted method. After adjustment for other risk factors, we found in premenopausal women that serum insulin-like growth factor-I levels, and in postmenopausal women, serum levels of prolactin, were both significantly and positively associated with per cent density. Total oestradiol and progesterone levels were unrelated to per cent density in both groups. In postmenopausal women, free oestradiol (negatively), and sex hormone binding globulin (positively), were significantly related to per cent density. These data show an association between blood levels of breast mitogens and mammographic density, and suggest a biological basis for the associated risk of breast cancer.

MeSH Terms
Adult Biomarkers, Tumor/blood Breast/pathology Breast Neoplasms/blood,diagnostic imaging Cross-Sectional Studies Estradiol/blood Female Humans Insulin-Like Growth Factor Binding Protein 3/blood Insulin-Like Growth Factor I/metabolism Mammography Middle Aged Mitogens/metabolism Postmenopause Premenopause Progesterone/blood Prolactin/blood Risk Factors Sex Hormone-Binding Globulin/metabolism
Chemicals
Biomarkers, Tumor Insulin-Like Growth Factor Binding Protein 3 Mitogens Sex Hormone-Binding Globulin Progesterone Estradiol Insulin-Like Growth Factor I Prolactin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Boyd N F
Division of Epidemiology and Statistics, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, Canada M5G 1K9. boyd@oci.utoronto.ca
Stone J
Martin L J
Jong R
Fishell E
Yaffe M
Hammond G
Minkin S
References (54)
54 references, click to expand
  1. X-ray characterisation of normal and neoplastic breast tissues.
    Phys Med Biol. 1987 Jun;32(6):675-95 PMID: 3039542
  2. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women.
    Eur J Cancer Clin Oncol. 1988 Jul;24(7):1225-31 PMID: 3416905
  3. Age and race related changes in mammographic parenchymal patterns.
    Cancer. 1989 Jun 15;63(12):2537-9 PMID: 2720602
  4. Regulation of sex hormone-binding globulin production by growth factors.
    Metabolism. 1990 Sep;39(9):967-70 PMID: 2168012
  5. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients.
    J Natl Cancer Inst. 1990 Nov 7;82(21):1693-7 PMID: 2231756
  6. The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer.
    Cancer Treat Res. 1991;53:93-106 PMID: 1672092
  7. Insulin-like growth factors: biochemistry and physiology.
    Baillieres Clin Endocrinol Metab. 1991 Dec;5(4):531-51 PMID: 1721807
  8. Insulin-like growth factors and cancer.
    Br J Cancer. 1992 Mar;65(3):311-20 PMID: 1313689
  9. Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitro.
    Eur J Cancer. 1992;28A(4-5):788-93 PMID: 1355980
  10. High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice.
    J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):237-42 PMID: 1525063
  11. Serum levels of growth hormone-binding protein and insulin-like growth factor-I during puberty.
    Clin Endocrinol (Oxf). 1992 Aug;37(2):175-80 PMID: 1395068
  12. Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development.
    Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10872-6 PMID: 1438291
  13. Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors.
    J Clin Endocrinol Metab. 1995 Jan;80(1):160-4 PMID: 7829605
  14. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
    J Natl Cancer Inst. 1995 Feb 1;87(3):190-7 PMID: 7707406
  15. The role of prolactin in the menopause.
    Maturitas. 1994 Dec;20(2-3):151-4 PMID: 7715467
  16. Mammographic features and breast cancer risk: effects with time, age, and menopause status.
    J Natl Cancer Inst. 1995 Nov 1;87(21):1622-9 PMID: 7563205
  17. The role of growth hormone/insulin-like growth factors in adipocyte differentiation.
    Metabolism. 1995 Oct;44(10 Suppl 4):45-9 PMID: 7476311
  18. Gender differences in secretory activity of the human somatotropic (growth hormone) axis.
    Eur J Endocrinol. 1996 Mar;134(3):287-95 PMID: 8616524
  19. Automated analysis of mammographic densities.
    Phys Med Biol. 1996 May;41(5):909-23 PMID: 8735257
  20. Symmetry of projection in the quantitative analysis of mammographic images.
    Eur J Cancer Prev. 1996 Oct;5(5):319-27 PMID: 8972250
  21. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Metabolism. 1997 Jan;46(1):5-9 PMID: 9005961
  22. Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: relationship with bone mineral density and lipid metabolism in perimenopausal women.
    Eur J Endocrinol. 1997 Jun;136(6):608-16 PMID: 9225724
  23. Growth hormone treatment induces mammary gland hyperplasia in aging primates.
    Nat Med. 1997 Oct;3(10):1141-4 PMID: 9334728
  24. Determinants of circulating insulin-like growth factor-I.
    J Endocrinol Invest. 1999;22(5 Suppl):48-57 PMID: 10442571
  25. Mammographic breast density during hormone replacement therapy: differences according to treatment.
    Am J Obstet Gynecol. 1999 Aug;181(2):348-52 PMID: 10454681
  26. Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG).
    J Steroid Biochem Mol Biol. 1999 Jul-Aug;70(1-3):73-80 PMID: 10529004
  27. The quantitative analysis of mammographic densities.
    Phys Med Biol. 1994 Oct;39(10):1629-38 PMID: 15551535
  28. Weight regulation, leptin and growth hormone.
    Horm Res. 1997;48 Suppl 5:116-21 PMID: 9434056
  29. The insulin-like growth factors and breast cancer--revisited.
    Breast Cancer Res Treat. 1998 Feb;47(3):197-9 PMID: 9516075
  30. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention.
    Breast Cancer Res Treat. 1998 Feb;47(3):209-17 PMID: 9516077
  31. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
    Lancet. 1998 May 9;351(9113):1393-6 PMID: 9593409
  32. Mammographic densities and breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1133-44 PMID: 9865433
  33. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group.
    Ann Intern Med. 1999 Feb 16;130(4 Pt 1):270-7 PMID: 10068384
  34. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.
    J Natl Cancer Inst. 1999 Apr 7;91(7):629-34 PMID: 10203283
  35. Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen.
    Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):863-6 PMID: 10548313
  36. Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knock-out mice.
    Proc Soc Exp Biol Med. 1999 Nov;222(2):113-23 PMID: 10564535
  37. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
    Cancer Res. 2000 Jul 15;60(14):3744-8 PMID: 10919644
  38. Tamoxifen and mammographic breast densities.
    Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):911-5 PMID: 11008908
  39. Effect of tamoxifen on mammographic density.
    Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):917-21 PMID: 11008909
  40. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy.
    JAMA. 2001 Jan 10;285(2):171-6 PMID: 11176809
  41. Growth factors and stromal matrix proteins associated with mammographic densities.
    Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):243-8 PMID: 11303594
  42. Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.
    Endocrine. 2001 Feb;14(1):45-62 PMID: 11322501
  43. Augmentation of prolactin secretion by estrogen in hypogonadal women.
    J Clin Invest. 1974 Feb;53(2):652-5 PMID: 11344580
  44. The role of prolactin in breast cancer.
    Recent Results Cancer Res. 1976;(57):143-9 PMID: 189373
  45. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Am J Obstet Gynecol. 1977 Nov 1;129(5):557-64 PMID: 910845
  46. Stimulatory effect of 2-hydroxyestradiol on prolactin release in hypogonadal women.
    J Clin Endocrinol Metab. 1980 Aug;51(2):413-5 PMID: 6772666
  47. Role of estrogen in the dopaminergic control of prolactin secretion.
    Endocrinology. 1981 Feb;108(2):440-4 PMID: 7449733
  48. The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin.
    Acta Endocrinol (Copenh). 1980 Dec;95(4):433-7 PMID: 6779473
  49. The relation of mammographic features of the breast to breast cancer risk factors.
    Am J Epidemiol. 1982 Mar;115(3):438-43 PMID: 7064978
  50. A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities.
    Clin Chim Acta. 1983 Jul 31;132(1):101-10 PMID: 6193907
  51. Breast cancer risk associated with reproductive factors and breast parenchymal patterns.
    J Natl Cancer Inst. 1984 Jun;72(6):1277-82 PMID: 6587148
  52. Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases.
    J Natl Cancer Inst. 1985 Nov;75(5):823-9 PMID: 3863985
  53. Factors associated with mammographic pattern.
    Br J Radiol. 1985 Jan;58(685):21-5 PMID: 4063637
  54. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt.
    Am J Dis Child. 1987 May;141(5):562-4 PMID: 3578171
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
2002-10-07
Pages
876-82
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2376176
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com